Therapeutic Recommendations for Nephroblastoma

French Africa Pediatric Oncology Group1,000 enrolled

Overview

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Nephroblastoma

Interventions

Data collectionOTHER

Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.

Eligibility

Sex: ALLMin age: 6 MonthsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Unilateral Nephroblastoma Tumor Not previously treated The general health of the child will permit treatment. . Exclusion Criteria: Bilateral Nephroblastoma tumor Previously treated Disease too advanced Doubt concerning the diagnosis Treatment Refusal

Locations (7)

Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle

Ouagadougou, Burkina Faso

RECRUITING

CHU de Treichville à ABIDJAN

Abidjan, Abidjan Autonomous District, Côte d’Ivoire

RECRUITING

CUK (Cliniques Universitaires de Kinshasa)

Outcomes

Primary Outcomes

Evaluation of the number of cases with local disease.

By evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis.

Time frame: 5 years

Evaluation of the number of cases with stage IV disease.

By evaluating the initial clinical reports and later histological reports to confirm the stage.

Time frame: 5 Years

Evaluating the treatment given.

Comparison of treatment given and recommended treatment.

Time frame: 5 Years

Evaluating the follow up after treatment.

How many children alive or dead after treatment

Time frame: 5 Years

Secondary Outcomes

Why has treatment failed

look at precision of reporting by comparing reports (histological and surgical)

Time frame: 5 years

Central Contacts

BRENDA Ms MALLON, MSC

CONTACT

0033142115411 brenda.mallon@gustaveroussy.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.